Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An integrated cross-platform prognosis study on neuroblastoma patients

31 Jul 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments
Share to Ubiquitin and proteasome pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18598751
DOI: 10.1016/j.ygeno.2008.05.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An integrated cross-platform prognosis study on neuroblastoma patientsPMID 18598751Read ↗

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH studySemantic proximity Read ↗

Cancer Classification at the CrossroadsSemantic proximity Read ↗

Update on neuroblastomaSemantic proximity Read ↗

Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic MelanomaSemantic proximity Read ↗

The Evolution of Risk Classification for NeuroblastomaSemantic proximity Read ↗

Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic researchSemantic proximity Read ↗

[Central core disease, multicore disease, minicore disease].Semantic proximity Read ↗

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene SignatureSemantic proximity Read ↗

Advances in Risk Classification and Treatment Strategies for NeuroblastomaSemantic proximity Read ↗

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingSemantic proximity Read ↗

Blinded Comparator Study of Immunohistochemical Analysis versus a 92-Gene Cancer Classifier in the Diagnosis of the Primary Site in Metastatic TumorsSemantic proximity Read ↗

Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.